SusanneMuehlschlegelMDMPH

Neurology • Baltimore, MD

Neurocritical Care

Professor (PAR) Johns Hopkins University School of Medicine

Join to view full profile

Dr. Muehlschlegel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Muehlschlegel's full profile

Already have an account?

Office
4940 Eastern Ave
Baltimore, MD 21224
Phone+1 410-550-5568

Fax+1 410-500-4266

Summary

I am a board-certified neurointensivist, a physician specialized in the critical care of brain and spinal cord injured patients. My clinical and research focus lies in helping critically ill patients with neurological injury survive with the best possible outcome, while also caring for their families.

Education & Training

Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Vascular Neurology, 2006 - 2007
University of FloridaResidency, Neurology, 2003 - 2006
University of FloridaInternship, Internal Medicine, 2002 - 2003
Univ Marburg- Faculty MedClass of 2002, MD, Dr. med, Magna Cum Laude

Certifications & Licensure

MA State Medical License 2006 - 2025
MD State Medical License 2023 - 2025
MD State Medical License 2023 - 2025
CT State Medical License 2009 - 2024
FL State Medical License 2005 - 2011
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Vascular Neurology

Awards, Honors, & Recognition

Member of Board of Directors Neurocritical Care Society
Councilor, Critical Care and Emergency Neurology Section American Academy of Neurology
Presidential Citation for Outstanding Contributions Neurocritical Care Society

Clinical Trials

Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial Start of enrollment: 2014 Oct 01
Completed
Phase 2
Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction Start of enrollment: 2018 Aug 29
Terminated
Phase 3
Impact of Fever Prevention in Brain Injured Patients Start of enrollment: 2017 Jan 01
Terminated
Not Applicable
Brain Oxygen Optimization in Severe TBI, Phase 3 Start of enrollment: 2019 Aug 28
Recruiting
Not Applicable
Shared Decision Making to Improve Goals-of-Care Decisions for Families of Severe Acute Brain Injury Patients Start of enrollment: 2018 Feb 11
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

25 citations
Cerebral vasospasm after aneurysmal subarachnoid hemorrhage and traumatic brain injury.
Saef Izzy, Susanne Muehlschlegel
Current Treatment Options in Neurology. 2014-01-01
140 citations
Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial.
Magdy Selim, Lydia D. Foster, Claudia S. Moy, Guohua Xi, Michael D. Hill
The Lancet. Neurology. 2019-05-01
19 citations
Prognostication and shared decision making in neurocritical care.
Kelsey Goostrey, Susanne Muehlschlegel
BMJ. 2022-04-07

Press Mentions

Prognostic Discord Between Families, Physicians Common in Acute Severe Brain InjuryOctober 22nd, 2021
Definition and Prioritization of Data Elements for Cohort Studies and Clinical Trials on Patients with Unruptured Intracranial Aneurysms: Proposal of a Multidisciplinary Research GroupMay 17th, 2019
Survival After Gunshot Injuries Predicted with New ToolOctober 27th, 2016
Join now to see all

Professional Memberships

Neurocritical Care Society
Member
American Heart Association - AHA
Member
American College of Critical Care Medicine - SCCM
Member
American Academy of Neurology - AAN
Member
American Neurological Association
Member

Other Languages

German

External Links

Muehlschlegel lab webpagehttp://www.umassmed.edu/nccresearch